We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
279 hedge funds and large institutions have $1.72B invested in Amphastar Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 99 increasing their positions, 93 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
248% more call options, than puts
Call options by funds: $3.91M | Put options by funds: $1.12M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
25% more capital invested
Capital invested by funds: $1.37B → $1.72B (+$343M)
4% more funds holding
Funds holding: 268 → 279 (+11)
2.53% more ownership
Funds ownership: 70.26% → 72.79% (+2.5%)
6% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 93
Holders
279
Holders Change
+11
Holders Change %
+4.1%
% of All Funds
4.01%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
43
Increased
99
Reduced
93
Closed
32
Calls
$3.91M
Puts
$1.12M
Net Calls
+$2.79M
Net Calls Change
+$2.61M
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$21M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.65M |
| 3 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$7.83M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.61M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.18M |
